(2) K Raun, B S Hansen, N L Johansen, H Thgersen, et al (1998) Ipamorelin, the first selective growth hormone secretagogue European Journal of Endocrinology, 1998 Nov, Volume 139 (Issue 5), Pages 552-61
GLP-1 use is linked to fewer kidney problems and lower blood sugar compared to other diabetes drugs RA patients who took GLP-1 or SGLT2 drugs had fewer flares Semaglutide was connected to better joint outcomes
A plain B12 (cyanocobalamin or methylcobalamin) shot supplies vitamin B12 to support normal energy metabolism
Why supervision matters: Dosing, monitoring, and side effect management ensure both safety and success
Preclinical research in rodents demonstrated that long-term, high-dose exposure to GLP-1 receptor agonists was associated with thyroid C-cell tumours (medullary thyroid carcinoma)
Side effects from the last increase have not fully resolved